The H. Lee Moffitt Cancer Center
-
Lary Robinson, M.D.Expert in mesothelioma and advanced lung cancer -
Craig W. Stevens, M.D., Ph.D.Department chair of Radiation Oncology
About The H. Lee Moffitt Cancer Center
Tampa, Florida, is the site of a major medical destination, the H. Lee Moffitt Cancer Center & Research Institute. Since opening in 1986, this institution, a partner with the University of South Florida (USF), has gained a well-regarded reputation as a leader in basic and translational cancer research, one instrumental in quickly taking discoveries from the laboratory directly to patients. As such, Moffitt has been designated by the National Cancer Institute (NCI) as one of the nation's 40 Comprehensive Cancer Centers, meaning it has demonstrated a substantial research program that covers clinical, laboratory and population-based research as well as a professional public education program for its local community.
Additionally, U.S. News & World Report listed Moffitt Cancer Center as one of the best hospitals in the nation for the treatment of cancer as well as the best in Florida. The 2010-2011 ranking is the 12th year in a row the hospital has received this recognition.
The ultimate goal of this full-service, 206-bed hospital is, quite simply, the prevention and cure of all cancer types. Moffitt has been designated by the National Cancer Institute as one of the nation's 40 Comprehensive Cancer Centers, meaning it maintains the highest standards of excellence in patient care, education, basic science, clinical research and cancer prevention.
As lung cancer and mesothelioma are such aggressive and deadly cancers, diagnosis and treatment requires a unique, specialized facility. At Moffitt, these diseases fall under the umbrella of the Thoracic Oncology Program, a team of national and international specialists representing the fields of oncology, pulmonology, surgery, pathology, radiation therapy and radiology.
This department has thrived under the leadership of Lary A. Robinson, M.D., director of the Division of Cardiovascular and Thoracic Surgery and an expert in the surgical management and research of mesothelioma and advanced lung cancer; and Craig W. Stevens, M.D., Ph.D., department chair of Radiation Oncology, with research interests in therapies for malignant and pleural mesothelioma. This team - which includes surgeons, medical oncologists, radiation therapists, pulmonologists, pathologists, nurses, social workers and nutritionists - embraces an interdisciplinary approach to coordinated cancer care and treatment.
For help finding other mesothelioma specialists, use the Doctor Match Program offered by the Mesothelioma Center.
Therapy for patients with malignant mesothelioma at Moffitt includes standard surgical options, such as wide local excisions and the removal of affected organs (pleurectomy and decortications). Radiation and/or chemotherapy may also be utilized following these procedures. But the Thoracic Oncology Program may also perform experimental, state-of-the-art techniques, such as biologic therapy ("immunotherapy"), in which the patient's own immune system is used to treat their cancer.
With more than 135 scientific investigators, Moffitt's research efforts cover six programs, all with an emphasis on taking laboratory discoveries and translating them into new and experimental therapies for cancer patients. Due to these research endeavors, Moffitt's total peer-reviewed grant funding is more than $75 million, including Specialized Programs of Research Excellence(SPORE) grant in lung cancer.
-
05/18/2012 -
The Queen of Disco Donna Summer died on Thursday in her Naples, Florida, home after a quiet battle with lung cancer.
She was 63.
The five-time G ..
-
05/17/2012 -
Thoracic surgeon Robert Cameron, M.D., used his second annual Symposium for Lung-Sparing Therapies for Malignant Pleural Mesothelioma last week in Los ..
-
05/17/2012 -
Researchers in Singapore have uncovered new technology for studying cancer stem cells that could spark quicker development of a more effective therapy ..
© 2012 The Mesothelioma Center |
Last Modified Friday, April 27th, 2012 | Disclaimer | Privacy Policy |
The information provided by The Mesothelioma Center is not a substitute for professional medical advice, diagnosis or treatment.
Sponsored by a law firm concentrating in asbestos litigation, The Peterson Firm, LLP with offices at 1350 Connecticut Ave, NW, Fifth Floor, Washington DC 20036.
